Another two... [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-16 23:41 (282 d 05:00 ago) – Posting: # 22575
Views: 3,538

Dear all,

It looks like the FDA has just keelhauled 2 CROs again: Panexcell and Synchron Research. The FDA will reject all data from both CROs due to data manipulation. All Panexcell data had already been rejected in the EU.

The FDA letters are very explicit regarding what they have found, and their conclusion is crystal clear:

Put simply, because you have been responsible for the creation of false data in the studies discussed here, we have no reason to believe that any data that you have produced are reliable. Thus, FDA has determined that all study data from all studies conducted at your firm must be rejected.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 23 (0 registered, 23 guests [including 3 identified bots]).
Forum time: Sunday 04:41 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5